At BIO 2026, Thermo Fisher's Anil Kane explains how AI is reshaping CDMO workflows and what biotechs should prioritize when choosing a development partner.
Nicholas Jacobus
Advertisement
Articles by Nicholas Jacobus
Trump to fire FDA Commissioner Marty Makary amid controversy over vaccine and drug policy decisions, leaving the agency without confirmed leadership.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Drapeau’s AI Deep Dive: The Price of Acceptance in Regulated AI
2
Regulatory Roundup—October 2026: FDA Advances Rare Disease Development and Transparency Efforts
3
AAPS PharmSci 360: How USP Is Tackling the Novel Excipient Roadblock
4
Why Drug Shortages Average 5+ Years: PharmTech Explained
5